181 related articles for article (PubMed ID: 15302898)
1. Erythropoietin reduces the development of experimental inflammatory bowel disease.
Cuzzocrea S; Mazzon E; Di Paola R; Patel NS; Genovese T; Muià C; De Sarro A; Thiemermann C
J Pharmacol Exp Ther; 2004 Dec; 311(3):1272-80. PubMed ID: 15302898
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide treatment reduces colon injury induced by experimental colitis.
Mazzon E; Muià C; Di Paola R; Genovese T; De Sarro A; Cuzzocrea S
Shock; 2005 Jun; 23(6):556-64. PubMed ID: 15897810
[TBL] [Abstract][Full Text] [Related]
3. Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis.
Di Paola R; Esposito E; Mazzon E; Riccardi L; Caminiti R; Dal Toso R; Pressi G; Cuzzocrea S
Biochem Pharmacol; 2009 Mar; 77(5):845-57. PubMed ID: 19070602
[TBL] [Abstract][Full Text] [Related]
4. The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease.
Impellizzeri D; Bruschetta G; Di Paola R; Ahmad A; Campolo M; Cuzzocrea S; Esposito E; Navarra M
Clin Nutr; 2015 Dec; 34(6):1146-54. PubMed ID: 25491246
[TBL] [Abstract][Full Text] [Related]
5. Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat.
Cuzzocrea S; McDonald MC; Mazzon E; Mota-Filipe H; Centorrino T; Terranova ML; Ciccolo A; Britti D; Caputi AP; Thiemermann C
Gut; 2001 Apr; 48(4):478-88. PubMed ID: 11247891
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminoisoquinolinone reduces colon injury by experimental colitis.
Cuzzocrea S; Mazzon E; Di Paola R; Genovese T; Patel NS; Muià C; Threadgill MD; De Sarro A; Thiemermann C
Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):464-73. PubMed ID: 15599708
[TBL] [Abstract][Full Text] [Related]
7. Role of poly(ADP-ribose) glycohydrolase in the development of inflammatory bowel disease in mice.
Cuzzocrea S; Mazzon E; Genovese T; Crisafulli C; Min WK; Di Paola R; Muià C; Li JH; Malleo G; Xu W; Massuda E; Esposito E; Zhang J; Wang ZQ
Free Radic Biol Med; 2007 Jan; 42(1):90-105. PubMed ID: 17157196
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats.
Cuzzocrea S; Mazzon E; Serraino I; Dugo L; Centorrino T; Ciccolo A; Sautebin L; Caputi AP
Eur J Pharmacol; 2001 Nov; 431(1):91-102. PubMed ID: 11716847
[TBL] [Abstract][Full Text] [Related]
9. Melatonin reduces dinitrobenzene sulfonic acid-induced colitis.
Cuzzocrea S; Mazzon E; Serraino I; Lepore V; Terranova ML; Ciccolo A; Caputi AP
J Pineal Res; 2001 Jan; 30(1):1-12. PubMed ID: 11168901
[TBL] [Abstract][Full Text] [Related]
10. Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis.
Cuzzocrea S; McDonald MC; Mazzon E; Dugo L; Lepore V; Fonti MT; Ciccolo A; Terranova ML; Caputi AP; Thiemermann C
Eur J Pharmacol; 2000 Oct; 406(1):127-37. PubMed ID: 11011044
[TBL] [Abstract][Full Text] [Related]
11. Thalidomide treatment reduces the alteration of paracellular barrier function in mice ileum during experimental colitis.
Mazzon E; Cuzzocrea S
Shock; 2006 May; 25(5):515-21. PubMed ID: 16680017
[TBL] [Abstract][Full Text] [Related]
12. The cyclopentenone prostaglandin 15-deoxy-delta(12,14)- PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat.
Cuzzocrea S; Ianaro A; Wayman NS; Mazzon E; Pisano B; Dugo L; Serraino I; Di Paola R; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
Br J Pharmacol; 2003 Feb; 138(4):678-88. PubMed ID: 12598422
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine kinase inhibitor tyrphostin AG 126 reduced the development of colitis in the rat.
Cuzzocrea S; McDonald MC; Mazzon E; Mota-Filipe H; Lepore V; Ciccolo A; Terranova ML; Britti D; Caputi AP; Thiemermann C
Lab Invest; 2000 Sep; 80(9):1439-53. PubMed ID: 11005212
[TBL] [Abstract][Full Text] [Related]
14. 5-lipoxygenase modulates the alteration of paracellular barrier function in mice ileum during experimental colitis.
Mazzon E; Sautebin L; Caputi AP; Cuzzocrea S
Shock; 2006 Apr; 25(4):377-83. PubMed ID: 16670640
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse.
Cuzzocrea S; Mazzon E; di Paola R; Genovese T; Patel NS; Britti D; de Majo M; Caputi AP; Thiemermann C
Arthritis Rheum; 2005 Mar; 52(3):940-50. PubMed ID: 15751086
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.
Antonioli L; Fornai M; Colucci R; Ghisu N; Da Settimo F; Natale G; Kastsiuchenka O; Duranti E; Virdis A; Vassalle C; La Motta C; Mugnaini L; Breschi MC; Blandizzi C; Del Taca M
J Pharmacol Exp Ther; 2007 Aug; 322(2):435-42. PubMed ID: 17488880
[TBL] [Abstract][Full Text] [Related]
17. Role of iNOS in hepatocyte tight junction alteration in mouse model of experimental colitis.
Mazzon E; Cuzzocrea S
Cell Mol Biol (Noisy-le-grand); 2003 Feb; 49(1):45-57. PubMed ID: 12839336
[TBL] [Abstract][Full Text] [Related]
18. GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat.
Mazzon E; Dugo L; Li JH; Di Paola R; Genovese T; Caputi AP; Zhang J; Cuzzocrea S
Biochem Pharmacol; 2002 Jul; 64(2):327-37. PubMed ID: 12123754
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid.
Di Paola R; Mazzon E; Patel NS; Genovese T; Muià C; Thiemermann C; De Sarro A; Cuzzocrea S
Eur J Pharmacol; 2005 Jan; 507(1-3):281-9. PubMed ID: 15659319
[TBL] [Abstract][Full Text] [Related]
20. 5-Lipoxygenase-derived lipid mediators are not required for the development of NSAID-induced inflammatory bowel disease in IL-10-/- mice.
Narushima S; DiMeo D; Tian J; Zhang J; Liu D; Berg DJ
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G477-88. PubMed ID: 18048478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
